• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


How's The Old New England Region Doing?





who's the new guy at joslin who marinates in cheap cologne and high fives his way down the hallways? really novo? he acts like joslin is affiliated to bunker hill community college instead of harvard.
 












Now she is a piece of work. Boston beware, she will smile to your face and knife you in the back to get whatever she wants.

She was let go from her group in the company and the old manager saved her for some reason. We just stare in amazement sometimes at what goes on around here. Don't get the attraction.
 




Now she is a piece of work. Boston beware, she will smile to your face and knife you in the back to get whatever she wants.

What do the do all day ? there is no place for them to go in the city everyone knows that. that is why they'll cut each others throat. they got no place to go after the pharma gig in Boston
 








































Could little davey come show us how to get into all the hospitals and doctor's offices in boston?

Hey, couldn't the whole hcs model be replaced by these low cost dca folks? I mean nobody believes that any of these people actually get into or know any docs or exec at a high level within these institutions. the new healthcare model is just a few payers and contacts , no reps need be involved. they're really just for show so why not dcas?
 




Hey, couldn't the whole hcs model be replaced by these low cost dca folks? I mean nobody believes that any of these people actually get into or know any docs or exec at a high level within these institutions. the new healthcare model is just a few payers and contacts , no reps need be involved. they're really just for show so why not dcas?

Makes perfect sense...oh wait, they all just got promoted!